gtag('event', 'click', { 'event_category': 'PDF Download' });
was successfully added to your cart.



CLDF joins call for Europe-wide shift in liver disease treatment

CLDF is one of the organisations who have contributed to a report calling for a fundamental shift in the way liver disease is prevented, diagnosed, and treated across Europe.

The report by the EASL Lancet Commission calls for a more integrated approach to enable earlier detection of liver disease and to bring common risk factors like alcohol and obesity under control. Liver disease is now the second leading cause of years of working life lost in Europe.

“We cannot ignore the fact that non-alcoholic fatty liver disease (NAFLD) is now the fastest growing liver disease in Europe,” says CLDF’s CEO, Alison Taylor, one of the authors of the report. “A joined-up approach across medical professionals and patient groups would enable us to take action against this and where there is an opportunity to prevent any young person developing a liver condition, it’s vital that we take it.”

You can read further details of the EASL Lancet Commission report – protecting the next generations of Europeans against liver disease complications and premature mortality here.

Leave a Reply

© 2019 Children's Liver Disease Foundation. All Rights Reserved.